Metformin Repurposing in Neurological Disorders: A Clinical Trial Landscape. [PDF]
R Y +8 more
europepmc +1 more source
The blind men and the elephant: recognising the multisystem symptoms of myotonic dystrophy type 1. [PDF]
Leeuwenberg KE +9 more
europepmc +1 more source
Quantitative Magnetic Resonance Imaging of the Forearm in Myotonic Dystrophy Type 1. [PDF]
Eierle S +9 more
europepmc +1 more source
Muscle-driven spinal cord histological and transcriptomic alterations in a myotonic dystrophy mouse model: insights into neuropathy. [PDF]
Shi G +7 more
europepmc +1 more source
Financial Toxicity and Its Determinants in Individuals Living With Inherited and Acquired Neuromuscular Disorders: The BIND Study. [PDF]
Grant A +12 more
europepmc +1 more source
IgG4-Related Disease Associated With Myotonic Dystrophy Type 2. [PDF]
Pegat A +5 more
europepmc +1 more source
Risk of Cardiac Disease in a Population-Based Cohort of Myotonic Dystrophy Type 1 and Type 2 in the United States. [PDF]
Johnson NE +11 more
europepmc +1 more source
Sudden Death Caused by Bilateral Diaphragmatic Eventration in Myotonic Dystrophy Type 1. [PDF]
Wu S, Prahlow JA.
europepmc +1 more source
A systems perspective on rare diseases: integrating human phenotype ontology with the Anukta framework of Ayurveda. [PDF]
Jangir D +4 more
europepmc +1 more source

